ArticleCancers2025

Delay of Systemic Therapy Confers a Survival Benefit in Patients with Stage IV Non-Small-Cell Lung Cancer.

Rike Geiken-Weinstock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.